Literature DB >> 7535634

Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1.

S W Hayward1, R Dahiya, G R Cunha, J Bartek, N Deshpande, P Narayan.   

Abstract

This report describes the development and characterization of an epithelial cell line (BPH-1) from human prostate tissue obtained by transurethral resection. Primary epithelial cell cultures were immortalized with SV40 large T antigen. One of the isolated clones was designated BPH-1. These cells have a cobblestone appearance in monolayer culture and are non-tumorigenic in nude mice following subcutaneous injection or subrenal capsule grafting. They express the SV40 large T antigen and exhibit increased levels of p53, as determined by immunocytochemistry. Cytogenetic analysis by G-banding demonstrated an aneuploid karyotype with a modal chromosome number of 76 (range 71 to 79, n = 28) and 6 to 8 marker chromosomes. Some structurally rearranged chromosomes were observed, but the Y chromosome was normal. The expressed cytokeratin profile was consistent with a prostatic luminal epithelial cell. This profile was the same as that of primary prostatic epithelial cultures from which the BPH-1 cells were derived. In serum-free culture in plastic dishes epidermal growth factor (EGF), transforming growth factor (TGF)-alpha, fibroblast growth factor (FGF) 1 (aFGF), and FGF 7 (KGF) induced increased proliferation in these cells whereas FGF 2 (bFGF), TGF-beta 1, and TGF-beta 2 inhibited proliferative activity. Testosterone had no direct effect on the proliferative rate of BPH-1 cells. 5 alpha-Reductase, 3 alpha-hydroxysteroid oxidoreductase, and 17 beta-hydroxy-steroid oxidoreductase activities were detected in BPH-1 cells. Expression of androgen receptors and the secretory markers, prostate specific antigen and prostatic acid phosphatase, were not detectable by immunocytochemistry, biochemical assay, or RT-PCR analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535634     DOI: 10.1007/BF02631333

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  64 in total

Review 1.  Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors.

Authors:  G R Cunha; E T Alarid; T Turner; A A Donjacour; E L Boutin; B A Foster
Journal:  J Androl       Date:  1992 Nov-Dec

2.  Urogastrone-epidermal growth factor concentrations in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy.

Authors:  H Gregory; I R Willshire; J P Kavanagh; N J Blacklock; S Chowdury; R C Richards
Journal:  Clin Sci (Lond)       Date:  1986-04       Impact factor: 6.124

3.  Effects of flutamide and hydroxy-flutamide on the growth of human benign prostatic hyperplasia cells in primary culture: a preliminary report.

Authors:  R Hallowes; S Cox; S Hayward; N Deshpande; J Towler
Journal:  Anticancer Res       Date:  1991 Sep-Oct       Impact factor: 2.480

4.  The LNCaP cell line--a new model for studies on human prostatic carcinoma.

Authors:  J S Horoszewicz; S S Leong; T M Chu; Z L Wajsman; M Friedman; L Papsidero; U Kim; L S Chai; S Kakati; S K Arya; A A Sandberg
Journal:  Prog Clin Biol Res       Date:  1980

5.  Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice.

Authors:  D D Mickey; K R Stone; H Wunderli; G H Mickey; D F Paulson
Journal:  Prog Clin Biol Res       Date:  1980

6.  Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines.

Authors:  G L Morris; J G Dodd
Journal:  J Urol       Date:  1990-06       Impact factor: 7.450

7.  Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus.

Authors:  J Bartek; J Bartkova; N Kyprianou; E N Lalani; Z Staskova; M Shearer; S Chang; J Taylor-Papadimitriou
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice.

Authors:  A A Donjacour; G R Cunha
Journal:  Endocrinology       Date:  1993-06       Impact factor: 4.736

9.  Androgens modulate epidermal growth factor receptor levels in the rat ventral prostate.

Authors:  R St-Arnaud; P Poyet; P Walker; F Labrie
Journal:  Mol Cell Endocrinol       Date:  1988-03       Impact factor: 4.102

10.  Epidermal growth factor and prostatic carcinoma: an immunohistochemical study.

Authors:  J E Fowler; J L Lau; L Ghosh; S E Mills; A Mounzer
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

View more
  134 in total

1.  A novel method for implantation of LNCaP prostate tumor cells under the renal capsule.

Authors:  R M Adam; A Orsola; M R Freeman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-06       Impact factor: 2.416

2.  Studies on the influence of DNA repair on radiosensitivity in prostate cell lines.

Authors:  Antonio M Serafin; John M Akudugu; Lothar Böhm
Journal:  Urol Res       Date:  2003-04-01

3.  Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1.

Authors:  Huarui Lu; Ping Liu; Yunqian Pan; Haojie Huang
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

4.  Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.

Authors:  Abdo J Najy; Joshua J Won; Lisa S Movilla; Hyeong-Reh C Kim
Journal:  Mol Cancer Res       Date:  2012-06-11       Impact factor: 5.852

5.  Modeling stromal-epithelial interactions in disease progression.

Authors:  Douglas W Strand; Simon W Hayward
Journal:  Discov Med       Date:  2010-06       Impact factor: 2.970

6.  Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumors.

Authors:  Cleo Y F Lee; Luke X X Bu; Arrigo DeBenedetti; B Jill Williams; Paul S Rennie; William W G Jia
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

7.  Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway.

Authors:  Jason B Garrison; Natasha Kyprianou
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

8.  Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.

Authors:  Nur Ozten Kandaş; Carla Randolph; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

9.  Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines.

Authors:  Breanne D W Karanikolas; Marxa L Figueiredo; Lily Wu
Journal:  Prostate       Date:  2010-05-01       Impact factor: 4.104

10.  Trichomonas vaginalis contact-dependent cytolysis of epithelial cells.

Authors:  Gila Lustig; Christopher M Ryan; W Evan Secor; Patricia J Johnson
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.